30-Day Readmissions Rule Under Two-Pronged Attack
The bottom line, they said, is that "readmissions may be a poor marker of hospital performance."
The second article, by Robert Berenson, MD, of the Urban Institute; Ronald Paulus, MD, of the Mission Health System, Asheville; and Noah Kalman of Duke University in Durham, makes a business case against the penalty.
In their article, "Medicare's Readmissions-Reduction Program—A Positive Alternative," the authors suggest that hospitals, notwithstanding financial penalties for hosp excessive readmissions, "have no economic incentive" under the DRG approach to change unless they are at full capacity. They give two reasons.
- They say the penalty "may be too weak to overcome the substantial counterincentives inherent in the DRG-based payments," which still pay hospitals in the fee-for-service system to care for readmitted patients. The actual reduction in spending avoided by the fines is only .2% of anticipated Medicare payments for 2013, because for most hospitals with average or better readmission rates, payment won't change
- They contend that he direct costs of a readmission prevention program—estimated to average $100 to $200 per discharge—may decrease hospitalizations for other diagnoses not targeted by the readmissions prevention rule.
- Interventional Radiology No Longer a Sub-Specialty
- CEO Exchange: Preparing for Population Health
- Advocate, NorthShore Deal Would Create 16-Hospital System
- Top Reason for Nurse Turnover: Managers
- CEO Exchange: Pressure is On to Partner, Drive Quality
- House OKs Cassidy's 'keep your plan' bill
- How MA plans to re-enroll 450,000 residents in health insurance
- 3 Strategies for Retaining Millennial Employees
- Behind the CVS Health Rebranding Strategy
- CMS Pitches Medicare Appeals Deal to Hospitals